474 related articles for article (PubMed ID: 28837075)
1. Botulinum Toxin for the Treatment of Neuropathic Pain.
Park J; Park HJ
Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28837075
[TBL] [Abstract][Full Text] [Related]
2. Botulinum Toxin for Neuropathic Pain: A Review of the Literature.
Oh HM; Chung ME
Toxins (Basel); 2015 Aug; 7(8):3127-54. PubMed ID: 26287242
[TBL] [Abstract][Full Text] [Related]
3. Botulinum Toxin for Central Neuropathic Pain.
Park J; Chung ME
Toxins (Basel); 2018 Jun; 10(6):. PubMed ID: 29857568
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin for neuropathic pain and spasticity: an overview.
Brown EA; Schütz SG; Simpson DM
Pain Manag; 2014 Mar; 4(2):129-51. PubMed ID: 24641437
[TBL] [Abstract][Full Text] [Related]
5. Neurobiological mechanisms of botulinum neurotoxin-induced analgesia for neuropathic pain.
Bagues A; Hu J; Alshanqiti I; Chung MK
Pharmacol Ther; 2024 Jul; 259():108668. PubMed ID: 38782121
[TBL] [Abstract][Full Text] [Related]
6. Do botulinum toxins have a role in the management of neuropathic pain?: a focused review.
Francisco GE; Tan H; Green M
Am J Phys Med Rehabil; 2012 Oct; 91(10):899-909. PubMed ID: 22660369
[TBL] [Abstract][Full Text] [Related]
7. [Use of intracutaneous or subcutaneous botulinum toxin for postherpetic neuralgia].
Halb L; Amann BJ; Bornemann-Cimenti H
Nervenarzt; 2017 Apr; 88(4):408-414. PubMed ID: 27924350
[TBL] [Abstract][Full Text] [Related]
8. Botulinum neurotoxin injections for muscle-based (dystonia and spasticity) and non-muscle-based (neuropathic pain) pain disorders: a meta-analytic study.
Siongco PRL; Rosales RL; Moore AP; Freynhagen R; Arimura K; Kanovsky P; Kaji R; Fernandez HH; Dressler D
J Neural Transm (Vienna); 2020 Jun; 127(6):935-951. PubMed ID: 32146504
[TBL] [Abstract][Full Text] [Related]
9. Botulinum Toxin Treatment of Neuropathic Pain.
Mittal SO; Safarpour D; Jabbari B
Semin Neurol; 2016 Feb; 36(1):73-83. PubMed ID: 26866499
[TBL] [Abstract][Full Text] [Related]
10. Use of Botulinum Toxin in Orofacial Clinical Practice.
Serrera-Figallo MA; Ruiz-de-León-Hernández G; Torres-Lagares D; Castro-Araya A; Torres-Ferrerosa O; Hernández-Pacheco E; Gutierrez-Perez JL
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32053883
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin treatment of pain syndromes -an evidence based review.
Safarpour Y; Jabbari B
Toxicon; 2018 Jun; 147():120-128. PubMed ID: 29409817
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous and perineural botulinum toxin type a for neuropathic pain: a descriptive review.
Fabregat G; De Andrés J; Villanueva-Pérez VL; Asensio-Samper JM
Clin J Pain; 2013 Nov; 29(11):1006-12. PubMed ID: 23370086
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound-Guided Nerve Block with Botulinum Toxin Type A for Intractable Neuropathic Pain.
Moon YE; Choi JH; Park HJ; Park JH; Kim JH
Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26761032
[TBL] [Abstract][Full Text] [Related]
14. Multidimensional Effectiveness of Botulinum Toxin in Neuropathic Pain: A Systematic Review of Randomized Clinical Trials.
Lippi L; de Sire A; Folli A; D'Abrosca F; Grana E; Baricich A; Carda S; Invernizzi M
Toxins (Basel); 2022 Apr; 14(5):. PubMed ID: 35622555
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature.
Sycha T; Kranz G; Auff E; Schnider P
J Neurol; 2004 Feb; 251 Suppl 1():I19-30. PubMed ID: 14991339
[TBL] [Abstract][Full Text] [Related]
16. A focused review on the use of botulinum toxins for neuropathic pain.
Argoff CE
Clin J Pain; 2002; 18(6 Suppl):S177-81. PubMed ID: 12569966
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Botulinum Toxin in the Treatment of Neuropathic Pain: A Literature Review.
Dekhne A; Goklani HD; Doshi N; Baskara Salian R; Gandhi SK; Patel P
Cureus; 2023 Oct; 15(10):e46848. PubMed ID: 37954779
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive Effects of Botulinum Toxin Type A on Trigeminal Neuropathic Pain.
Yang KY; Kim MJ; Ju JS; Park SK; Lee CG; Kim ST; Bae YC; Ahn DK
J Dent Res; 2016 Sep; 95(10):1183-90. PubMed ID: 27418174
[TBL] [Abstract][Full Text] [Related]
19. A novel therapeutic with two SNAP-25 inactivating proteases shows long-lasting anti-hyperalgesic activity in a rat model of neuropathic pain.
Wang J; Casals-Diaz L; Zurawski T; Meng J; Moriarty O; Nealon J; Edupuganti OP; Dolly O
Neuropharmacology; 2017 May; 118():223-232. PubMed ID: 28347837
[TBL] [Abstract][Full Text] [Related]
20. Is Botulinum Toxin Effective in Treating Orofacial Neuropathic Pain Disorders? A Systematic Review.
Val M; Delcanho R; Ferrari M; Guarda Nardini L; Manfredini D
Toxins (Basel); 2023 Sep; 15(9):. PubMed ID: 37755967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
